Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05554094
PHASE2

Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder

Sponsor: Ohio State University

View on ClinicalTrials.gov

Summary

The primary aim of this study is to assess the safety and efficacy of psilocybin-assisted therapy in the treatment of post-traumatic stress disorder in United States military Veterans.

Official title: Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial

Key Details

Gender

All

Age Range

21 Years - 64 Years

Study Type

INTERVENTIONAL

Enrollment

15

Start Date

2023-01-01

Completion Date

2026-07-31

Last Updated

2026-03-04

Healthy Volunteers

No

Interventions

DRUG

Psilocybin

Participants will receive 15 mg of oral psilocybin in the first session and 25 mg in the second session.

Locations (1)

Ohio State University Department of Psychiatry and Behavioral Health at the Davis Medical Research Center

Columbus, Ohio, United States